Murex Partners
Murex Partners is a Seoul-based, thesis-driven venture capital firm founded in 2018 that invests in early and mid-growth stage Korean startups across Consumer, Enterprise, and Healthcare sectors, managing 60+ portfolio companies and pursuing control acquisitions alongside minority equity deals.
- Company typePrivate
- Founded2017
- HeadquartersSeoul, South Korea
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Murex Partners does
Murex Partners (operating under the trading name ENKO) is a Seoul-based, thesis-driven venture capital firm founded in 2018 that invests in early and mid-growth stage Korean startups across Consumer, Enterprise, and Healthcare sectors. The firm manages a portfolio of 60+ companies and provides capital alongside strategic guidance, leveraging a network of successful prior portfolio entrepreneurs who have become venture partners (including the CEOs of Yanolja, Lake Investment, and Global Networks). Documented outcomes include three successful exits: a KOSDAQ IPO of Smart Radar System (ticker 424960) and M&A exits of TissenBioFarm, Cenacle, and Pet-friends.
The firm's business model centers on minority equity investments in Korean startups at the early-to-mid growth stage, with check sizes implied by participation in rounds such as Konnex's 15 billion won Series C (March 2026). In 2026, Murex signaled a strategic expansion into control acquisitions: it secured negotiation rights and is conducting due diligence to acquire a controlling stake in Soolnok, the operator of K-beauty brand VIVELAB, at a discussed corporate value exceeding 50 billion won. The firm has also built a dedicated M&A team separate from its Tech and IR/Operations functions, indicating an operational shift toward buyout-style investing.
Murex distributes capital and strategic support rather than products or services; it maintains a professional online presence through its corporate website (murexpartners.com) and a Medium publication, and operates from the 13th floor of a Dosan-daero office building near Apgujeong Rodeo Station in Gangnam-gu, Seoul. The ownership structure, LP base, and AUM are not publicly disclosed. Recent co-investment relationships span Premier Partners, ES Investors, Suin Investment Capital, The Next Lab, and strategic partner Pharma Research.
Murex Partners firmographics
Firmographics- Name
- Murex Partners
- Legal name
- Murex Partners
- Website
- http://murexpartners.com/
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Murex Partners is a Seoul-based, thesis-driven venture capital firm founded in 2018 that invests in early and mid-growth stage Korean startups across Consumer, Enterprise, and Healthcare sectors, managing 60+ portfolio companies and pursuing control acquisitions alongside minority equity deals.
- Ownership category
- akta.pro rank
Murex Partners industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire) (FSANAHAG)
Keywords
Where Murex Partners is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Murex Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Marketing channels2 records
Murex Partners product offering
Product offeringCore offering
Murex Partners is a Korean venture capital firm that invests capital and provides strategic support to early and mid-growth stage startups in Korea. The firm operates on a thesis-driven investment model across Consumer, Enterprise, and Healthcare sectors, supplementing capital with mentorship from successful entrepreneurs who serve as venture partners.
Product overview
Murex Partners is a Korean venture capital firm that provides investment services for early and mid-growth stage companies. Rather than offering a unified technology product, the firm operates as an investment platform focused on thesis-driven investments in Korean entrepreneurs across Consumer, Enterprise, and Healthcare sectors. The firm leverages deep industry expertise and relationships to support portfolio companies, with successful entrepreneurs often becoming venture partners who collaborate closely with the firm.
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital Investment Services Murex Partners provides equity capital investment and strategic support to early and mid-growth stage companies in Korea, with a thesis-driven investment approach and long-term partnerships with entrepreneurs. The service targets Korean startups across Consumer, Enterprise, and Healthcare sectors, supplemented by mentorship from a network of successful entrepreneurs serving as venture partners.
Companies that use Murex Partners
Customer profileSegments1 record
Ideal customer profiles1 record
Murex Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Murex Partners partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Pharma ResearchcoreStrategic investor in Konnex's Series C, extending beyond existing licensing agreement for core pipeline CNT201 into a share-based long-term collaboration combining Konnex's recombinant protein technology with Pharma Research's global commercialization capabilities.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Murex Partners competitors and assessment
Company assessmentDirect peers
- Altos Ventures: Early-to-growth stage venture firm with deep Korea exposure, thesis-driven approach, and operators-turned-partners model — directly comparable to Murex Partners' strategy of investing in Korean founders across consumer and tech.
- Primer (Primer Sazze Partners): Korean early-stage VC investing across consumer and tech verticals; comparable to Murex Partners in stage focus, Korean market emphasis, and sector breadth.
- Strong Ventures: US-Korea cross-border early-stage VC; comparable in Korean market focus and founder-supportive, thesis-driven approach, though with stronger US network.
- BonAngels Venture Partners: Korean seed and early-stage VC focused on Korean founders; comparable to Murex Partners in early-stage focus and Korea-centric thesis, though typically earlier-stage.
- Capstone Partners: Korean VC firm investing in early and growth-stage companies across multiple sectors including consumer, enterprise, and healthcare — directly comparable stage and sector exposure to Murex Partners.
- InterVest (Wind Ventures): Korean early-to-growth stage VC with diversified sector coverage; comparable stage and Korean market focus to Murex Partners.
Broad incumbents
- Korea Investment Partners: One of Korea's largest and most established VC firms with broad sector coverage and significant AUM; broader incumbent operating in the same Korean early-to-growth investment space.
- SoftBank Ventures Asia: Large Asia-focused venture arm of SoftBank Group investing across Korean and Asian early-to-growth stage companies; broader incumbent competing for the same Korean tech deals.
- POSCO Capital: Korean CVC affiliated with POSCO, investing across growth-stage Korean companies including healthcare and enterprise; broader incumbent with corporate LP/strategic angle.
- KB Investment: Major Korean VC and CVC platform affiliated with KB Financial Group; operates at much larger scale but competes for the same Korean mid-growth deals across similar sectors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Murex Partners social profiles
Digital presenceMurex Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Murex Partners leadership team
Management profileNumber of profiles
Profiles9 records
Murex Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Murex Partners M&A and investment
M&A and investmentM&A
Investments99 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Murex Partners
What does Murex Partners do?
Murex Partners is a Korean venture capital firm that invests capital and provides strategic support to early and mid-growth stage startups in Korea. The firm operates on a thesis-driven investment model across Consumer, Enterprise, and Healthcare sectors, supplementing capital with mentorship from successful entrepreneurs who serve as venture partners.
Is Murex Partners a public or private company?
Murex Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Murex Partners founded?
Murex Partners was founded in 2017. It employs 1 to 10 people.
Where is Murex Partners based?
Murex Partners is headquartered in Seoul, South Korea, in the Asia region.
Who are Murex Partners's main competitors?
Direct peers on record are Altos Ventures, Primer (Primer Sazze Partners), Strong Ventures, BonAngels Venture Partners, Capstone Partners and InterVest (Wind Ventures). Broad incumbents are Korea Investment Partners, SoftBank Ventures Asia, POSCO Capital and KB Investment.
Does Murex Partners have an API?
No public API is recorded for Murex Partners.
What industry is Murex Partners in?
Murex Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAHAG, Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire). Its NAICS code is 523940 and its SIC code is 6282.